| Literature DB >> 30037041 |
Hossain Mohammad Arif Ullah1, Junhyeong Kim2, Naveed Ur Rehman3, Hye-Jin Kim4, Mi-Jeong Ahn5, Hye Jin Chung6.
Abstract
Rumex acetosa (Entities:
Keywords: LC-MS/MS; aglycone; anthraquinone; glycoside; plasma; protein precipitation
Year: 2018 PMID: 30037041 PMCID: PMC6161010 DOI: 10.3390/pharmaceutics10030100
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1The chemical structures of six anthraquinones and diclofenac (internal standard). E, emodin; EG, emodin-8-O-β-d-glucoside; C, chrysophanol; CG, chrysophanol-8-O-β-d-glucoside; P, physcion; PG, physcion-8-O-β-d-glucoside.
Summary of the MS/MS parameters.
| Compounds | MRM Transition ( | Fragmentor (V) | Collision Energy (V) |
|---|---|---|---|
| E | 269 → 225 | 145 | 20 |
| EG | 431 → 269 | 150 | 24 |
| C | 253 → 225 | 175 | 22 |
| CG | 415 → 253 | 89 | 13 |
| P | 283 → 240 | 157 | 16 |
| PG | 445 → 283 | 95 | 5 |
| IS (Diclofenac) | 294 → 250 | 65 | 1 |
a MRM transitions refer to the reference [12]. MRM, multiple reaction monitoring; E, emodin; EG, emodin-8-O-β-d-glucoside; C, chrysophanol; CG, chrysophanol-8-O-β-d-glucoside; P, physcion; PG, physcion-8-O-β-d-glucoside; IS, internal standard.
Figure 2MS/MS scan spectra of six anthraquinones. (A) chrysophanol; (B) chrysophanol-8-O-β-d-glucoside; (C) emodin; (D) emodin-8-O-β-d-glucoside; (E) physcion; (F) physcion-8-O-β-d-glucoside.
Figure 3Representative MRM chromatograms of IS, EG, CG, PG, E, C, and P in rat plasma. (A) blank plasma; (B) blank plasma spiked with six anthraquinones (250 ng/mL for aglycones and 125 ng/mL for glycosides) and IS; (C) plasma sample obtained from rats 45 min after oral administration of R. acetosa extract (2 g/kg).
Accuracy and precision of anthraquinones in rat plasma (n = 6). RSD: relative standard deviation.
| Analyte | Nominal Concentration (ng/mL) | Intra-Batch | Inter-Batch | ||||
|---|---|---|---|---|---|---|---|
| Mean Calculated Concentration (ng/mL) | Accuracy (%) | RSD (%) | Mean Calculated Concentration (ng/mL) | Accuracy (%) | RSD (%) | ||
| P | 20 | 20.5 | 102.5 | 8.83 | 21.3 | 106.4 | 11.2 |
| 60 | 58.0 | 96.7 | 4.69 | 63.4 | 105.6 | 7.72 | |
| 150 | 156 | 104.2 | 3.98 | 158 | 105.3 | 5.90 | |
| 300 | 308 | 102.6 | 2.80 | 312 | 104.1 | 5.54 | |
| E | 1 | 1.10 | 110.1 | 13.5 | 1.05 | 104.6 | 11.1 |
| 3 | 3.31 | 110.3 | 6.87 | 3.12 | 103.9 | 6.87 | |
| 150 | 155 | 103.4 | 2.32 | 154 | 102.8 | 2.66 | |
| 300 | 309 | 103.0 | 3.45 | 299 | 99.8 | 2.28 | |
| C | 20 | 21.8 | 109.2 | 9.23 | 19.8 | 98.9 | 2.98 |
| 60 | 64.1 | 106.9 | 7.79 | 59.3 | 98.9 | 5.75 | |
| 150 | 153 | 101.9 | 4.91 | 155 | 103.1 | 6.85 | |
| 300 | 303 | 101.1 | 3.94 | 321 | 107.0 | 4.20 | |
| PG | 10 | 10.2 | 102.1 | 10.7 | 10.2 | 102.3 | 12.1 |
| 30 | 32.1 | 107.1 | 6.83 | 31.7 | 105.7 | 5.72 | |
| 75 | 80.3 | 107.1 | 5.38 | 80.5 | 107.3 | 4.95 | |
| 150 | 160 | 106.5 | 4.13 | 159 | 106.2 | 4.89 | |
| EG | 1 | 1.10 | 110.1 | 18.9 | 1.05 | 105.2 | 9.10 |
| 3 | 3.35 | 111.8 | 5.49 | 3.27 | 108.9 | 12.9 | |
| 75 | 77.3 | 103.0 | 1.59 | 78.5 | 104.6 | 3.85 | |
| 150 | 156 | 104.1 | 1.24 | 153.9 | 102.6 | 4.34 | |
| CG | 10 | 11.2 | 111.9 | 8.34 | 11.0 | 109.9 | 8.00 |
| 30 | 31.5 | 105.0 | 4.13 | 31.6 | 105.4 | 5.79 | |
| 75 | 76.3 | 101.7 | 2.72 | 76.5 | 102.0 | 3.16 | |
| 150 | 154 | 102.9 | 3.87 | 157 | 104.5 | 2.12 | |
Extraction recovery and matrix effect of anthraquinones in rat plasma (n = 3).
| Analyte | Nominal Concentration (ng/mL) | Extraction Recovery (%) | Matrix Effect (%) | ||
|---|---|---|---|---|---|
| Mean | RSD | Mean | RSD | ||
| P | 60 | 106.5 | 4.85 | 185.6 | 2.29 |
| 150 | 106.4 | 1.23 | 185.1 | 3.13 | |
| 300 | 98.6 | 1.49 | 183.9 | 3.92 | |
| E | 3 | 101.3 | 2.74 | 70.1 | 6.65 |
| 150 | 105.6 | 0.82 | 87.0 | 1.46 | |
| 300 | 100.4 | 1.90 | 92.3 | 2.77 | |
| C | 60 | 112.7 | 8.71 | 143.0 | 1.04 |
| 150 | 102.1 | 1.07 | 144.3 | 1.62 | |
| 300 | 96.6 | 1.04 | 144.6 | 4.11 | |
| PG | 30 | 106.4 | 13.0 | 42.5 | 8.41 |
| 75 | 107.4 | 5.60 | 44.3 | 6.07 | |
| 150 | 96.6 | 3.14 | 51.4 | 2.33 | |
| EG | 3 | 97.6 | 3.48 | 286.5 | 4.29 |
| 75 | 100.5 | 0.77 | 277.6 | 3.60 | |
| 150 | 97.6 | 1.25 | 277.8 | 2.84 | |
| CG | 30 | 96.0 | 1.36 | 113.8 | 6.64 |
| 75 | 96.6 | 6.01 | 121.9 | 3.24 | |
| 150 | 96.5 | 6.89 | 126.7 | 2.02 | |
Stability of anthraquinones in rat plasma (n = 3).
| Analyte | Conc. (ng/mL) | Short Term Stability (%) | Long Term Stability (%) | Freeze and Thaw Stability (%) | Processed Sample Stability (%) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Accuracy | RSD | Accuracy | RSD | Accuracy | RSD | Accuracy | RSD | ||
| P | 60 | 104.9 | 2.05 | 107.3 | 5.31 | 103.6 | 8.18 | 102.2 | 9.10 |
| 150 | 98.9 | 5.64 | 100.1 | 2.34 | 103.9 | 4.48 | 101.6 | 2.87 | |
| 300 | 103.8 | 2.39 | 98.0 | 2.00 | 104.2 | 3.21 | 102.7 | 5.76 | |
| E | 3 | 103.2 | 3.46 | 106.8 | 4.25 | 107.5 | 2.38 | 108.2 | 5.26 |
| 150 | 100.7 | 2.55 | 107.8 | 1.87 | 104.5 | 4.32 | 108.0 | 5.96 | |
| 300 | 101.8 | 2.44 | 107.7 | 0.93 | 102.0 | 3.47 | 104.6 | 3.60 | |
| C | 60 | 103.5 | 6.23 | 104.3 | 8.67 | 89.7 | 0.76 | 101.5 | 9.60 |
| 150 | 98.6 | 1.07 | 97.9 | 7.67 | 91.8 | 3.94 | 103.7 | 5.43 | |
| 300 | 101.2 | 2.97 | 102.6 | 2.98 | 92.4 | 8.25 | 102.3 | 6.47 | |
| PG | 30 | 98.9 | 9.48 | 97.7 | 5.64 | 101.5 | 9.06 | 98.8 | 6.33 |
| 75 | 91.8 | 6.60 | 98.5 | 5.36 | 94.3 | 6.57 | 92.7 | 4.64 | |
| 150 | 96.7 | 1.62 | 97.1 | 2.85 | 93.6 | 2.16 | 96.8 | 1.19 | |
| EG | 3 | 99.8 | 5.11 | 102.9 | 4.02 | 100.4 | 6.39 | 91.5 | 3.11 |
| 75 | 108.5 | 2.79 | 107.9 | 1.54 | 112.3 | 3.60 | 107.9 | 2.88 | |
| 150 | 98.9 | 1.81 | 102.8 | 2.14 | 100.9 | 1.69 | 100.3 | 4.14 | |
| CG | 30 | 97.6 | 9.29 | 97.5 | 4.04 | 98.3 | 4.81 | 91.1 | 2.45 |
| 75 | 96.9 | 0.56 | 100.6 | 1.38 | 101.0 | 2.23 | 100.2 | 7.38 | |
| 150 | 101.8 | 5.27 | 101.5 | 2.52 | 97.0 | 5.66 | 96.7 | 5.93 | |
Figure 4Mean plasma concentration–time profiles after oral (n = 3) administration of R. acetosa extract (2 g/kg) to SD male rats. Bars represent standard deviation. (A) emodin; (B) physcion-8-O-β-d-glucoside; (C) chrysophanol; (D) chrysophanol-8-O-β-d-glucoside.
The pharmacokinetic parameters of anthraquinones after oral administration of R. acetosa extract to rats at a dose of 2 g/kg (n = 3).
| Analyte | AUC0–last a (ng h/mL) | Cmax (ng/mL) | Tmax b (h) | MRT (h) | t1/2 (h) |
|---|---|---|---|---|---|
| C | 265.6 ± 70.9 | 155.6 ± 86.0 | 0.25 (0.25–0.5) | 2.4 ± 0.2 | 3.9 ± 0.6 |
| E | 1165 ± 336.1 | 123.5 ± 41.7 | 0.25 (0.25–0.75) | 7.7 ± 3.0 | NA |
| CG | 158.0 ± 12.3 | 28.7 ± 4.7 | 2 (0.75–2) | 2.4 ± 0.08 | 4.8 ± 0.5 |
| PG | 82.8 ± 13.8 | 20.5 ± 1.4 | 0.75 (0.5–2) | 2.7 ± 0.6 | 6.2 ± 3.9 |
The values were expressed as mean ± standard deviation except Tmax. a The last measured time points for C, E, CG, and PG were 6, 24, 8, and 6 h. b Median (range). AUC0–last, total area under the plasma concentration–time curve from time zero to last measured time; Cmax, maximum plasma concentration; Tmax, time to reach Cmax; MRT, mean residence time; t1/2, half-life; NA, not available.
Comparison with reported analytical methods for aglycones and glycosides of anthraquinone.
| Analytical Condition | Our Method | Lin et al. [ | Wang et al. [ | Ma et al. [ | |
|---|---|---|---|---|---|
| Sample volume | 20 μL | 25 μL | 25 μL | 100 μL | |
| Sample preparation | Protein precipitation | Solid phase extraction | Liquid-liquid extraction | Liquid-liquid extraction | |
| Target compounds | E, C, P, EG, CG, PG | EG, E | E, C, P, EG, CG, PG | EG, E | |
| LLOQ (ng/mL) | E | 1 | 1 | 2 | 9.6 |
| C | 20 | - | 50 | - | |
| P | 20 | - | 50 | - | |
| EG | 1 | 1 | 2 | 33.7 | |
| CG | 10 | - | 2 | - | |
| PG | 10 | - | 1 | - | |